Senicapoc, a drug developed to treat sickle cell anemia, being studied for COVID-19
by Press Release from Outbreak News Today on (#53EC1)
Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19. UC Davis Health researchers provided one of those repurposed drugs, senicapoc, to launch a clinical trial at Aarhus University in Denmark. The study will assess whether the drug can mitigate lung damage in patients with COVID-19. Senicapoc [...]
The post Senicapoc, a drug developed to treat sickle cell anemia, being studied for COVID-19 appeared first on Outbreak News Today.